COVID-19 therapies: do we see substantial progress?
Cell Mol Biol Lett
; 27(1): 42, 2022 May 31.
Article
de En
| MEDLINE
| ID: mdl-35641916
ABSTRACT
The appearance of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and its spread all over the world is the cause of the coronavirus disease 2019 (COVID-19) pandemic, which has recently resulted in almost 400 million confirmed cases and 6 million deaths, not to mention unknown long-term or persistent side effects in convalescent individuals. In this short review, we discuss approaches to treat COVID-19 that are based on current knowledge of the mechanisms of viral cell receptor recognition, virus-host membrane fusion, and inhibition of viral RNA and viral assembly. Despite enormous progress in antiviral therapy and prevention, new effective therapies are still in great demand.
Mots clés
Texte intégral:
1
Collection:
01-internacional
Base de données:
MEDLINE
Sujet principal:
COVID-19
Limites:
Humans
Langue:
En
Journal:
Cell Mol Biol Lett
Sujet du journal:
BIOLOGIA MOLECULAR
Année:
2022
Type de document:
Article
Pays d'affiliation:
Pologne